Latest Insider Transactions at Spectrum Pharmaceuticals Inc (SPPI)
This section provides a real-time view of insider transactions for Spectrum Pharmaceuticals Inc (SPPI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SPECTRUM PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SPECTRUM PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
14,658
-5.31%
|
$0
$0.7 P/Share
|
|
Mar 15
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,130
-8.23%
|
$0
$0.7 P/Share
|
|
Feb 24
2022
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,958
-4.31%
|
$0
$0.64 P/Share
|
|
Feb 24
2022
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
15,031
-5.17%
|
$0
$0.64 P/Share
|
|
Feb 24
2022
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
18,441
-2.94%
|
$0
$0.64 P/Share
|
|
Feb 24
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,708
-4.6%
|
$0
$0.64 P/Share
|
|
Feb 23
2022
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,215
-5.23%
|
$0
$0.7 P/Share
|
|
Feb 23
2022
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
13,513
-4.44%
|
$0
$0.7 P/Share
|
|
Feb 23
2022
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
19,953
-3.09%
|
$0
$0.7 P/Share
|
|
Feb 23
2022
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,466
-4.04%
|
$0
$0.7 P/Share
|
|
Feb 14
2022
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+5.55%
|
$0
$0.68 P/Share
|
|
Nov 09
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.79%
|
$12,000
$2.18 P/Share
|
|
Nov 08
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,363
-2.15%
|
$14,726
$2.2 P/Share
|
|
Jun 23
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.45%
|
$20,000
$4.0 P/Share
|
|
Jun 22
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,821
-1.66%
|
$23,284
$4.09 P/Share
|
|
Jun 22
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.46%
|
$18,000
$4.16 P/Share
|
|
Jun 21
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
3,735
-1.2%
|
$14,940
$4.27 P/Share
|
|
Jun 18
2021
|
William Ashton Director |
SELL
Open market or private sale
|
Direct |
9,000
-16.09%
|
$36,000
$4.24 P/Share
|
|
Jun 18
2021
|
Dolatrai Vyas |
SELL
Open market or private sale
|
Direct |
9,000
-9.44%
|
$36,000
$4.24 P/Share
|
|
Jun 18
2021
|
Seth H. Z. Fischer Director |
SELL
Open market or private sale
|
Direct |
12,000
-25.65%
|
$48,000
$4.24 P/Share
|
|
Jun 17
2021
|
William Ashton Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+20.33%
|
-
|
|
Jun 17
2021
|
Dolatrai Vyas |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+13.02%
|
-
|
|
Jun 17
2021
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+23.38%
|
-
|
|
Jun 17
2021
|
Bernice R Welles Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+18.17%
|
-
|
|
Jun 17
2021
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+8.18%
|
-
|
|
Jun 17
2021
|
Nora Brennan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,277
+32.78%
|
-
|
|
May 14
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
525
-0.17%
|
$1,575
$3.07 P/Share
|
|
May 14
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
2,250
-0.55%
|
$6,750
$3.07 P/Share
|
|
May 13
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
434
-0.14%
|
$1,302
$3.09 P/Share
|
|
May 13
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
3,402
-0.82%
|
$10,206
$3.09 P/Share
|
|
Apr 07
2021
|
Jeff L Vacirca Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+12.05%
|
$60,000
$3.15 P/Share
|
|
Apr 06
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,025
-0.29%
|
$3,075
$3.24 P/Share
|
|
Apr 05
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,125
-0.32%
|
$3,375
$3.31 P/Share
|
|
Apr 01
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
2,200
-0.7%
|
$6,600
$3.3 P/Share
|
|
Mar 31
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
1,739
-0.55%
|
$5,217
$3.2 P/Share
|
|
Mar 16
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,318
-3.92%
|
$48,954
$3.69 P/Share
|
|
Mar 16
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,828
-5.06%
|
$56,484
$3.69 P/Share
|
|
Mar 16
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
16,318
-4.9%
|
$48,954
$3.69 P/Share
|
|
Mar 16
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
18,828
-4.36%
|
$56,484
$3.69 P/Share
|
|
Mar 16
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
28,243
-4.76%
|
$84,729
$3.69 P/Share
|
|
Mar 15
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,365
-4.66%
|
$61,095
$3.62 P/Share
|
|
Mar 15
2021
|
Francois Lebel Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
22,631
-5.74%
|
$67,893
$3.62 P/Share
|
|
Mar 15
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
14,362
-4.13%
|
$43,086
$3.62 P/Share
|
|
Mar 15
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
23,291
-5.12%
|
$69,873
$3.62 P/Share
|
|
Mar 15
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
40,091
-6.33%
|
$120,273
$3.62 P/Share
|
|
Feb 22
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.09%
|
$15,000
$3.73 P/Share
|
|
Feb 22
2021
|
Kurt A Gustafson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,000
-0.91%
|
$12,000
$3.73 P/Share
|
|
Feb 22
2021
|
Keith M Mc Gahan Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.14%
|
$12,000
$3.73 P/Share
|
|
Feb 22
2021
|
Joseph W. Turgeon CEO & President |
SELL
Open market or private sale
|
Direct |
7,500
-1.17%
|
$22,500
$3.73 P/Share
|
|
Feb 19
2021
|
Thomas J Riga Director |
SELL
Open market or private sale
|
Direct |
5,018
-1.08%
|
$15,054
$3.64 P/Share
|